{"transactions":[{"id":3633,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-03T23:09:24.000Z","date":"2026-09-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":104954,"derivative":{"exercise_price":12.95,"exercise_date":"2020-03-19","expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-382277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526382277/ownership.xml","form_type":"4"}},{"id":3632,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-03T23:09:24.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":208.65,"value":2086500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $206.41 and $210.34."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-382277","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526382277/ownership.xml","form_type":"4"}},{"id":3631,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-03T23:09:24.000Z","date":"2026-09-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":12.95,"value":129500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-382277","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526382277/ownership.xml","form_type":"4"}},{"id":692934,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T23:00:04.000Z","date":"2026-08-06","kind":"exercise","planned":true,"acquired":false,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":0,"derivative":{"exercise_price":213.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001193125-26-340688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526340688/ownership.xml","form_type":"4"}},{"id":692933,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T23:00:04.000Z","date":"2026-08-05","kind":"exercise","planned":true,"acquired":false,"shares":45004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":4660,"derivative":{"exercise_price":212.01,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":45004},"source":{"system":"sec-edgar","filing":"0001193125-26-340688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526340688/ownership.xml","form_type":"4"}},{"id":692932,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-07T23:00:04.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":4660,"price":213.95,"value":997007.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $212.41 and $216.36."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-340688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526340688/ownership.xml","form_type":"4"}},{"id":692931,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-07T23:00:04.000Z","date":"2026-08-06","kind":"exercise","planned":true,"acquired":true,"shares":4660,"price":4.95,"value":23067.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":11889,"source":{"system":"sec-edgar","filing":"0001193125-26-340688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526340688/ownership.xml","form_type":"4"}},{"id":692930,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-07T23:00:04.000Z","date":"2026-08-05","kind":"sale","planned":true,"acquired":false,"shares":45004,"price":212.01,"value":9541298.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $209.28 and $216.35."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-340688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526340688/ownership.xml","form_type":"4"}},{"id":692929,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-07T23:00:04.000Z","date":"2026-08-05","kind":"exercise","planned":true,"acquired":true,"shares":45004,"price":4.95,"value":222769.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":52233,"source":{"system":"sec-edgar","filing":"0001193125-26-340688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526340688/ownership.xml","form_type":"4"}},{"id":720862,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T23:30:11.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":49666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":49664,"derivative":{"exercise_price":240.25,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":49666},"source":{"system":"sec-edgar","filing":"0001193125-26-292985","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526292985/ownership.xml","form_type":"4"}},{"id":720861,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:30:11.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":49666,"price":240.25,"value":11932256.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $237.64 and $244.71."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-292985","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526292985/ownership.xml","form_type":"4"}},{"id":720860,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:30:11.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":49666,"price":4.95,"value":245846.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":56895,"source":{"system":"sec-edgar","filing":"0001193125-26-292985","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526292985/ownership.xml","form_type":"4"}},{"id":741443,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":30518,"kind":"person","name":"JEFFS ROGER","position":1,"cik":"0001231615","reported_name":"JEFFS ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T00:34:11.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":286,"price":249.12,"value":71248.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025."}],"balance_after":58367,"source":{"system":"sec-edgar","filing":"0001193125-26-268202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231615/000119312526268202/ownership.xml","form_type":"4"}},{"id":741442,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":30518,"kind":"person","name":"JEFFS ROGER","position":1,"cik":"0001231615","reported_name":"JEFFS ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T00:34:11.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":286,"price":246.18,"value":70407.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025."}],"balance_after":58653,"source":{"system":"sec-edgar","filing":"0001193125-26-268202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231615/000119312526268202/ownership.xml","form_type":"4"}},{"id":742919,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":30518,"kind":"person","name":"JEFFS ROGER","position":1,"cik":"0001231615","reported_name":"JEFFS ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-11T01:49:45.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001193125-26-266437","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231615/000119312526266437/ownership.xml","form_type":"4"}},{"id":742918,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":30518,"kind":"person","name":"JEFFS ROGER","position":1,"cik":"0001231615","reported_name":"JEFFS ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:45.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":58939,"source":{"system":"sec-edgar","filing":"0001193125-26-266437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231615/000119312526266437/ownership.xml","form_type":"4"}},{"id":742964,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-11T01:49:38.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001193125-26-266436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526266436/ownership.xml","form_type":"4"}},{"id":742963,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:38.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":11431,"source":{"system":"sec-edgar","filing":"0001193125-26-266436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526266436/ownership.xml","form_type":"4"}},{"id":743056,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-11T01:49:26.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001193125-26-266435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000119312526266435/ownership.xml","form_type":"4"}},{"id":743055,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:26.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":300,"price":246.18,"value":73854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025."}],"balance_after":829,"source":{"system":"sec-edgar","filing":"0001193125-26-266435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000119312526266435/ownership.xml","form_type":"4"}},{"id":743054,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:26.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":300,"price":237.21,"value":71163.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025."}],"balance_after":1129,"source":{"system":"sec-edgar","filing":"0001193125-26-266435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000119312526266435/ownership.xml","form_type":"4"}},{"id":743053,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:26.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":1429,"source":{"system":"sec-edgar","filing":"0001193125-26-266435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000119312526266435/ownership.xml","form_type":"4"}},{"id":743105,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-11T01:49:14.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":false,"shares":1429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1429},"source":{"system":"sec-edgar","filing":"0001193125-26-266433","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526266433/ownership.xml","form_type":"4"}},{"id":743104,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:14.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":643,"price":249,"value":160107.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $245.17 and $253.04."}],"balance_after":30389,"source":{"system":"sec-edgar","filing":"0001193125-26-266433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526266433/ownership.xml","form_type":"4"}},{"id":743103,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:49:14.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":true,"shares":1429,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":31032,"source":{"system":"sec-edgar","filing":"0001193125-26-266433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526266433/ownership.xml","form_type":"4"}},{"id":744600,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:18:39.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."}],"balance_after":1721,"derivative":{"underlying":"Common Stock","underlying_shares":1721},"source":{"system":"sec-edgar","filing":"0001193125-26-264041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526264041/ownership.xml","form_type":"4"}},{"id":744519,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:18:11.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."}],"balance_after":1721,"derivative":{"underlying":"Common Stock","underlying_shares":1721},"source":{"system":"sec-edgar","filing":"0001193125-26-264040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000119312526264040/ownership.xml","form_type":"4"}},{"id":744367,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:17:33.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":false,"shares":49670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":99330,"derivative":{"exercise_price":241.01,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":49670},"source":{"system":"sec-edgar","filing":"0001193125-26-264038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526264038/ownership.xml","form_type":"4"}},{"id":744366,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:17:33.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":49670,"price":241.01,"value":11970966.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $236.11 and $244.13."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-264038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526264038/ownership.xml","form_type":"4"}},{"id":744365,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:17:33.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":true,"shares":49670,"price":4.95,"value":245866.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":56899,"source":{"system":"sec-edgar","filing":"0001193125-26-264038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526264038/ownership.xml","form_type":"4"}},{"id":744244,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:17:05.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":false,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":72000,"derivative":{"exercise_price":3.5,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001193125-26-264035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526264035/ownership.xml","form_type":"4"}},{"id":744243,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:17:05.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":33000,"price":240.09,"value":7922970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $236.46 and $242.35."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":42867,"source":{"system":"sec-edgar","filing":"0001193125-26-264035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526264035/ownership.xml","form_type":"4"}},{"id":744242,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-09T21:17:05.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":true,"shares":33000,"price":3.5,"value":115500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for over 8 years and exercised prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":75867,"source":{"system":"sec-edgar","filing":"0001193125-26-264035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526264035/ownership.xml","form_type":"4"}},{"id":744449,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:16:19.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."}],"balance_after":1721,"derivative":{"underlying":"Common Stock","underlying_shares":1721},"source":{"system":"sec-edgar","filing":"0001193125-26-264034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526264034/ownership.xml","form_type":"4"}},{"id":744386,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":30518,"kind":"person","name":"JEFFS ROGER","position":1,"cik":"0001231615","reported_name":"JEFFS ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-09T21:15:51.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":1721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the one-year anniversary of the date of grant."}],"balance_after":1721,"derivative":{"underlying":"Common Stock","underlying_shares":1721},"source":{"system":"sec-edgar","filing":"0001193125-26-264030","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231615/000119312526264030/ownership.xml","form_type":"4"}},{"id":754750,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:00:04.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":5537,"price":223.39,"value":1236910.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $221.82 and $225.21."}],"balance_after":29603,"source":{"system":"sec-edgar","filing":"0001193125-26-254038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526254038/ownership.xml","form_type":"4"}},{"id":754749,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:00:04.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":230.3,"value":1381800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $229.56 and $232.14."}],"balance_after":35140,"source":{"system":"sec-edgar","filing":"0001193125-26-254038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526254038/ownership.xml","form_type":"4"}},{"id":754748,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:00:04.000Z","date":"2026-05-29","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":233.46,"value":1400760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $231.50 and $235.23."}],"balance_after":41140,"source":{"system":"sec-edgar","filing":"0001193125-26-254038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526254038/ownership.xml","form_type":"4"}},{"id":791801,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-06T00:34:35.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":false,"shares":233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":114954,"derivative":{"exercise_price":12.95,"exercise_date":"2020-03-19","expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":233},"source":{"system":"sec-edgar","filing":"0001193125-26-207148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526207148/ownership.xml","form_type":"4"}},{"id":791800,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-06T00:34:35.000Z","date":"2026-05-04","kind":"exercise","planned":true,"acquired":false,"shares":4517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":115187,"derivative":{"exercise_price":12.95,"exercise_date":"2020-03-19","expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":4517},"source":{"system":"sec-edgar","filing":"0001193125-26-207148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526207148/ownership.xml","form_type":"4"}},{"id":791799,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:34:35.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":233,"price":228.18,"value":53165.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $225.01 and $230.77."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-207148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526207148/ownership.xml","form_type":"4"}},{"id":791798,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:34:35.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":true,"shares":233,"price":12.95,"value":3017.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":233,"source":{"system":"sec-edgar","filing":"0001193125-26-207148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526207148/ownership.xml","form_type":"4"}},{"id":791797,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:34:35.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":4517,"price":227.94,"value":1029604.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $225.12 and $231.97."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-207148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526207148/ownership.xml","form_type":"4"}},{"id":791796,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:34:35.000Z","date":"2026-05-04","kind":"exercise","planned":true,"acquired":true,"shares":4517,"price":12.95,"value":58495.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":4517,"source":{"system":"sec-edgar","filing":"0001193125-26-207148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526207148/ownership.xml","form_type":"4"}},{"id":801907,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-24T01:02:45.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":8669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."}],"balance_after":8669,"derivative":{"underlying":"Common Stock","underlying_shares":8669},"source":{"system":"sec-edgar","filing":"0001193125-26-174419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526174419/ownership.xml","form_type":"4"}},{"id":801748,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-24T01:02:29.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":24081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."}],"balance_after":24081,"derivative":{"underlying":"Common Stock","underlying_shares":24081},"source":{"system":"sec-edgar","filing":"0001193125-26-174417","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526174417/ownership.xml","form_type":"4"}},{"id":801978,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-24T01:01:34.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":23710,"derivative":{"exercise_price":70.73,"exercise_date":"2024-09-25","expiration_date":"2033-09-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001193125-26-174415","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526174415/ownership.xml","form_type":"4"}},{"id":801977,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-04-24T01:01:34.000Z","date":"2026-04-22","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":182.42,"value":1368150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $181.01 and $184.28."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-174415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526174415/ownership.xml","form_type":"4"}},{"id":801976,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-04-24T01:01:34.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":70.73,"value":530475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001193125-26-174415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526174415/ownership.xml","form_type":"4"}},{"id":801975,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-24T01:01:02.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":7224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."}],"balance_after":7224,"derivative":{"underlying":"Common Stock","underlying_shares":7224},"source":{"system":"sec-edgar","filing":"0001193125-26-174413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526174413/ownership.xml","form_type":"4"}},{"id":801684,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-04-24T01:00:44.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":8188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."}],"balance_after":8188,"derivative":{"underlying":"Common Stock","underlying_shares":8188},"source":{"system":"sec-edgar","filing":"0001193125-26-174412","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526174412/ownership.xml","form_type":"4"}},{"id":801952,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51496,"kind":"person","name":"Murdock Hunter R.","position":1,"cik":"0001934008","reported_name":"Murdock Hunter R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Performance Stock Units","published_at":"2026-04-24T01:00:20.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":7224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date."}],"balance_after":7224,"derivative":{"underlying":"Common Stock","underlying_shares":7224},"source":{"system":"sec-edgar","filing":"0001193125-26-174411","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1934008/000119312526174411/ownership.xml","form_type":"4"}},{"id":876962,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-28T00:10:09.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":54623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 26, 2030. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2025 Long-Term Incentive Plan (\"2025 Plan\")), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the 2025 Plan), or termination due to death or Total and Permanent Disability (as defined in the 2025 Plan)), or (iii) seven (7) years from the date of grant."}],"balance_after":54623,"derivative":{"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":54623},"source":{"system":"sec-edgar","filing":"0001193125-26-083609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526083609/ownership.xml","form_type":"4"}},{"id":876635,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-28T00:10:07.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":18570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 26, 2030. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2025 Long-Term Incentive Plan (\"2025 Plan\")), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the 2025 Plan), or termination due to death or Total and Permanent Disability (as defined in the 2025 Plan)), or (iii) seven (7) years from the date of grant."}],"balance_after":18570,"derivative":{"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":18570},"source":{"system":"sec-edgar","filing":"0001193125-26-083608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526083608/ownership.xml","form_type":"4"}},{"id":877536,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51496,"kind":"person","name":"Murdock Hunter R.","position":1,"cik":"0001934008","reported_name":"Murdock Hunter R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-28T00:10:06.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":16385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 26, 2030. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2025 Long-Term Incentive Plan (\"2025 Plan\")), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the 2025 Plan), or termination due to death or Total and Permanent Disability (as defined in the 2025 Plan)), or (iii) seven (7) years from the date of grant."}],"balance_after":16385,"derivative":{"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":16385},"source":{"system":"sec-edgar","filing":"0001193125-26-083607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1934008/000119312526083607/ownership.xml","form_type":"4"}},{"id":877694,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-28T00:10:04.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":16385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 26, 2030. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2025 Long-Term Incentive Plan (\"2025 Plan\")), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the 2025 Plan), or termination due to death or Total and Permanent Disability (as defined in the 2025 Plan)), or (iii) seven (7) years from the date of grant."}],"balance_after":16385,"derivative":{"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":16385},"source":{"system":"sec-edgar","filing":"0001193125-26-083606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526083606/ownership.xml","form_type":"4"}},{"id":877372,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-28T00:10:03.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":19663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 26, 2030. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2025 Long-Term Incentive Plan (\"2025 Plan\")), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the 2025 Plan), or termination due to death or Total and Permanent Disability (as defined in the 2025 Plan)), or (iii) seven (7) years from the date of grant."}],"balance_after":19663,"derivative":{"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":19663},"source":{"system":"sec-edgar","filing":"0001193125-26-083605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526083605/ownership.xml","form_type":"4"}},{"id":877263,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-28T00:00:07.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":161.11,"value":4027750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of underlying shares of previously exercised stock options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $160.33 and $162.26."}],"balance_after":47140,"source":{"system":"sec-edgar","filing":"0001193125-26-083587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526083587/ownership.xml","form_type":"4"}},{"id":877371,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-28T00:00:06.000Z","date":"2026-02-26","kind":"exercise","planned":true,"acquired":false,"shares":35378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":0,"derivative":{"exercise_price":2.85,"exercise_date":"2019-03-12","expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":35378},"source":{"system":"sec-edgar","filing":"0001193125-26-083586","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526083586/ownership.xml","form_type":"4"}},{"id":877370,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-28T00:00:06.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":35378,"price":161.88,"value":5726990.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $160.10 and $163.42."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-083586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526083586/ownership.xml","form_type":"4"}},{"id":877369,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":2470,"kind":"person","name":"Jacobson Mark L.","position":1,"cik":"0001805812","reported_name":"Jacobson Mark L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-28T00:00:06.000Z","date":"2026-02-26","kind":"exercise","planned":true,"acquired":true,"shares":35378,"price":2.85,"value":100827.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":35378,"source":{"system":"sec-edgar","filing":"0001193125-26-083586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805812/000119312526083586/ownership.xml","form_type":"4"}},{"id":881979,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-26T00:00:03.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":7721,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001193125-26-072481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526072481/ownership.xml","form_type":"4"}},{"id":881978,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T00:00:03.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":true,"shares":6250,"price":4.95,"value":30937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":72140,"source":{"system":"sec-edgar","filing":"0001193125-26-072481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526072481/ownership.xml","form_type":"4"}},{"id":888083,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-24T00:23:38.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":12485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":13971,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":12485},"source":{"system":"sec-edgar","filing":"0001193125-26-064681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526064681/ownership.xml","form_type":"4"}},{"id":888082,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T00:23:38.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":12485,"price":4.95,"value":61800.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":65890,"source":{"system":"sec-edgar","filing":"0001193125-26-064681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526064681/ownership.xml","form_type":"4"}},{"id":911921,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-11T00:11:27.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":false,"shares":5193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":0,"derivative":{"exercise_price":8.02,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":5193},"source":{"system":"sec-edgar","filing":"0001193125-26-045110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526045110/ownership.xml","form_type":"4"}},{"id":911920,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39665,"kind":"person","name":"Coleman Mark","position":1,"cik":"0001658379","reported_name":"Coleman Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-11T00:11:27.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":true,"shares":5193,"price":8.02,"value":41647.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares."}],"balance_after":53405,"source":{"system":"sec-edgar","filing":"0001193125-26-045110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658379/000119312526045110/ownership.xml","form_type":"4"}},{"id":924659,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T23:30:04.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":32410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":0,"derivative":{"exercise_price":185.6,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":32410},"source":{"system":"sec-edgar","filing":"0001193125-26-033973","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526033973/ownership.xml","form_type":"4"}},{"id":924658,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-02T23:30:04.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":32410,"price":185.6,"value":6015296.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $183.85 and $186.89."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-033973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526033973/ownership.xml","form_type":"4"}},{"id":924657,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-02T23:30:04.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":32410,"price":8.02,"value":259928.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed."}],"balance_after":39639,"source":{"system":"sec-edgar","filing":"0001193125-26-033973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526033973/ownership.xml","form_type":"4"}},{"id":932009,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-24T00:00:04.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":105000,"derivative":{"exercise_price":3.5,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001193125-26-021378","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526021378/ownership.xml","form_type":"4"}},{"id":932008,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T00:00:04.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":187.92,"value":2255040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $185.09 and $191.12."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":42588,"source":{"system":"sec-edgar","filing":"0001193125-26-021378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526021378/ownership.xml","form_type":"4"}},{"id":932007,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39961,"kind":"person","name":"Pizzie Nick","position":1,"cik":"0001742143","reported_name":"Pizzie Nick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T00:00:04.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":true,"shares":12000,"price":3.5,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options which was held for 8 years and exercised prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":54588,"source":{"system":"sec-edgar","filing":"0001193125-26-021378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526021378/ownership.xml","form_type":"4"}},{"id":932531,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-24T00:00:03.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":31210,"derivative":{"exercise_price":70.73,"exercise_date":"2024-09-25","expiration_date":"2033-09-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001193125-26-021377","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526021377/ownership.xml","form_type":"4"}},{"id":932530,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T00:00:03.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":184.44,"value":1383300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $183.70 and $184.81."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-021377","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526021377/ownership.xml","form_type":"4"}},{"id":932529,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":51503,"kind":"person","name":"Maizel Ari","position":1,"cik":"0002042289","reported_name":"Maizel Ari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-24T00:00:03.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":70.73,"value":530475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001193125-26-021377","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042289/000119312526021377/ownership.xml","form_type":"4"}},{"id":944188,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":false,"shares":31261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":32410,"derivative":{"exercise_price":170.38,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":31261},"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944187,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":29450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":63671,"derivative":{"exercise_price":172.33,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":29450},"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944186,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":false,"shares":78703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":93121,"derivative":{"exercise_price":171.28,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":78703},"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944185,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":31261,"price":170.38,"value":5326249.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $168.15 and $173.17."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944184,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":true,"shares":31261,"price":8.02,"value":250713.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":38490,"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944183,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":29450,"price":172.33,"value":5075118.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $170.36 and $175.26."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944182,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":29450,"price":8.02,"value":236189.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":36679,"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944181,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":78703,"price":171.28,"value":13480249.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $168.58 and $178.60."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":944180,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T00:00:20.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":true,"shares":78703,"price":8.02,"value":631198.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":85932,"source":{"system":"sec-edgar","filing":"0001193125-26-006695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312526006695/ownership.xml","form_type":"4"}},{"id":955081,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":false,"shares":31346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":0,"derivative":{"exercise_price":4.95,"exercise_date":"2018-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":31346},"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955080,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":false,"shares":6231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":0,"derivative":{"exercise_price":8.02,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":6231},"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955079,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":31346,"price":165.18,"value":5177732.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09."}],"balance_after":10002,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955078,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":true,"shares":31346,"price":4.95,"value":155162.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":41348,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955077,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"sale","planned":true,"acquired":false,"shares":6231,"price":165.18,"value":1029236.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09."}],"balance_after":10002,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":955076,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":39625,"kind":"person","name":"Saad Mark E","position":1,"cik":"0001295913","reported_name":"Saad Mark E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-03T00:02:02.000Z","date":"2025-12-31","kind":"exercise","planned":true,"acquired":true,"shares":6231,"price":8.02,"value":49972.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an exercise of stock options prior to the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":16233,"source":{"system":"sec-edgar","filing":"0001193125-26-001181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295913/000119312526001181/ownership.xml","form_type":"4"}},{"id":980105,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":false,"shares":10558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":171824,"derivative":{"exercise_price":148.18,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":10558},"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980104,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":false,"shares":20163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":182382,"derivative":{"exercise_price":146.94,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":20163},"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980103,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":false,"shares":49252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":202545,"derivative":{"exercise_price":144.59,"exercise_date":"2017-05-27","expiration_date":"2026-05-27","underlying":"Common Stock","underlying_shares":49252},"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980102,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":10558,"price":148.18,"value":1564484.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $146.77 and $149.41."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980101,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":10558,"price":8.02,"value":84675.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":17787,"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980100,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":20163,"price":146.94,"value":2962751.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $142.66 and $148.39."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980099,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":true,"shares":20163,"price":8.02,"value":161707.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":27392,"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980098,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":49252,"price":144.59,"value":7121346.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $141.79 and $149.23."}],"balance_after":7229,"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}},{"id":980097,"issuer":{"id":2469,"kind":"organization","name":"Axsome Therapeutics, Inc.","symbol":"AXSM"},"owners":[{"id":25398,"kind":"person","name":"TABUTEAU HERRIOT","position":1,"cik":"0001219927","reported_name":"TABUTEAU HERRIOT","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:39:43.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":true,"shares":49252,"price":8.02,"value":395001.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such transaction was pursuant to a pre-approved 10b5-1 plan."}],"balance_after":56481,"source":{"system":"sec-edgar","filing":"0001193125-25-308354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219927/000119312525308354/ownership.xml","form_type":"4"}}],"next_cursor":"2025-12-05T00:39:43.000000Z,980097"}